Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: A prospective study in a single center

Clinical and Experimental Nephrology

Volumn 12, Issue 4, 2008, Pages 250-255

  Koike, Minako ^a   Takei, Takashi ^a   Uchida, Keiko ^a   Honda, Kazuho ^a   Moriyama, Takahito ^a   Horita, Shigeru ^a   Ogawa, Tetsuya ^a   Yoshida, Takumi ^a   Tsuchiya, Ken ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Creatinine; Dipyridamole; IgA nephropathy; Prednisolone; Proteinuria; Vascular changes

Indexed keywords

ANTITHROMBOCYTIC AGENT; CREATININE; DIPYRIDAMOLE; PREDNISOLONE; PROTEIN; ZILAZEP;

ADULT; ARTICLE; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REDUCTION; FEMALE; HEMATURIA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; KIDNEY BIOPSY; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VASCULAR LESION;

ADULT; BIOPSY; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HUMANS; KIDNEY; MALE; MIDDLE AGED; PREDNISOLONE; PROSPECTIVE STUDIES; PROTEINURIA; TREATMENT OUTCOME;

EID: 47649131332     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-008-0036-7     Document Type: Article

References (18)

1. J Berger N. Hinglais 1968 Les deposits intercapillarired'IgA-IgG J Urol Nephrol. 74 694 5
2. G D'Amico L Minetti C Ponticelli G Fellin F Ferrario G Barbiano di Belgioioso 1986 Prognostic indicators in idiopathic IgA mesangial nephropathy Q J Med. 59 363 78
3. A Koyama M Igarashi M. Kobayashi 1997 Natural history and risk factors for immunoglobulin A nephropathy in Japan Am J Kidney Dis. 29 526 32
4. Y Kobayashi Y Hiki T Kokubo A Horii S. Tateno 1996 Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study Nephron. 72 237 42
5. L Nolin M. Courteau 1999 Management of IgA nephropathy: evidence-based recommendations Kidney Int Suppl. 70 S56 S62
6. C Pozzi P Bolasco GB Fogazzi S Andrulli P Altieri C Ponticelli 1999 Corticosteroids in IgA nephropathy: a randomized controlled trial Lancet. 353 883 7
7. T Shoji I Nakanishi A Suzuki T Hayashi M Togawa N Okada 2000 Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy Am J Kidney Dis. 35 194 201
8. S Taneda K Honda K Nitta H Kobayashi K Uchida W Yumura 1999 Clinicopathological study of IgA nephropathy in adults: the influence of onset age on clinical and renal histological findings and on the effect of steroid therapy Clin Exp Nephrol. 3 96 103
9. G D'Amico G Colasanti G Barbiano di Belgioioso G Fellin A Ragni F Egidi 1987 Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients Semin Nephrol. 4 355 8
10. E Alamartine JC Sabatier C Guerin JM Berliet F. Berthoux 1991 Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analysis Am J Kidney Dis. 1 12 19
11. JV Donadio EJ Bergstralh KP Offord 1994 Clinical and histopathological associations with impaired renal function in IgA nephropathy Clin Nephrol. 41 65 71
12. FW Ballardie IS. Roberts 2002 Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy J Am Soc Nephrol. 13 142 8
13. KN Lai FM Lai CP Ho KW. Chan 1986 Corticosteroid therapy in IgA nephropathy with nephritic syndrome: a long-term controlled trial Clin Nephrol. 26 174 180
14. S Tamura K Ueki H Ideura Y Tsukada A Maezawa H Kawai 2001 Corticosteroid therapy in patients with IgA nephropathy with impaired renal function Clin Nephrol. 55 192 5
15. Y Tomiyoshi T Sakemi Y Ikeda Y Ohtsuka M Nakamura T. Fujisaki 2001 Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy Internal Med. 40 862 6
16. Moriyama T, Honda K, Nitta K, Yumura W, Nihei H. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol. 2004;237-42.
17. K Honda K Nitta H Kobayashi K Uchida S Horita A Kawashima 2000 Clinical significance of histological grading and staging for predicting the effectiveness of steroid therapy in IgA nephropathy Clin Exp Nephrol. 4 241 250
18. R Katafuchi K Ikeda T Mizumasa H Tanaka T Ando T Yanase 2003 Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy Am J Kidney Dis. 41 972 83